Syros Pharmaceuticals (SYRS) Earnings Date & Reports

Industry: @Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

SYRS is expected to report earnings to rise 346.87% to -71 cents per share on March 06

Syros Pharmaceuticals SYRS Stock Earnings Reports

Q4'24

Est.

$-0.71

Q3'24

Beat

by $0.52

Q2'24

Beat

by $0.18

Q1'24

Beat

by $0.75

Q4'23

Est.

$-2.18

The last earnings report on October 31 showed earnings per share of -15 cents, beating the estimate of -68 cents. With 535.94K shares outstanding, the current market capitalization sits at 5.61M.

View a ticker or compare two or three

Compare

SYRS

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For SYRS
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a therapeutics company focusing on discovering and developing novel gene control therapies

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

35 CambridgePark Drive

Phone

+1 617 744-1340

Employees

Web

https://www.syros.com